Imaging
Researchers from the United States, United Kingdom and Turkey report recent findings in imaging
Published in Women's Health Weekly, August 24th, 2006
Study 1: Breast magnetic resonance imaging screening for BRCA1/2 carriers may be cost-effective.
"Women with inherited BRCA1/2 mutations are at high risk for breast cancer, which mammography often misses. Screening with contrast-enhanced breast magnetic resonance imaging (MRI) detects cancer earlier but increases costs and results in more false-positive scans," according to investigators writing in the Journal of the American Medical Association.
S.K. Plevritis and colleagues of Stanford University sought "to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Adult weight gain is associated with increased risk of breast cancer in postmenopausal women - Breast Cancer
Women with breast cancer are cautioned against phytoestrogens for menopausal symptoms - Dental Research
Hormones may play key role in notable gender differences in dental caries rates - Diet & Nutrition
Consumption of soy protein versus meat affects calcium absorption in women - Osteoporosis
Nitric oxide polymorphisms may not be associated with bone strength in older women - Alcohol Use
Marital therapy may be more effective at treating female alcoholics than traditional methods - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
